<DOC>
	<DOCNO>NCT00297128</DOCNO>
	<brief_summary>- feasibility tolerance preoperative therapy Cetuximab combination Capecitabine radiotherapy patient locally advance operable rectal carcinoma - collection response rate ( T-downstaging , pathological complete remission ) , correlation responsiveness EGFR-status</brief_summary>
	<brief_title>Preoperative Chemoradiation With Capecitabine Cetuximab</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Age : 1880 bioptical confirm adenocarcinoma rectum operable T3T4NxM0 status . In spite infiltration neighbour organ tumor basically surgically complete resectable former chemotherapy , radiotherapy pelvis abdomen and/or tumor resection rectum carcinoma WHO performance status 02 adequate bone marrow reserve ( granulocytes 1.500/µl ; thrombocyte 100.000/µl ) adequate hepatic function ( bilirubin 1.5 x ULN ; GOT GPT 3.5 x ULN ) adequate renal function ( creatinin 1.5 mg/dl ) woman childbearing potential : exclusion pregnancy ( negative urin serum pregnancy test ) willingness woman childbearing potential accordingly potent men use approve contraceptive ( e.g . birthcontrol pill , loop , condom ) least 3 month conclusion study life expectancy least 3 month sign Informed Consent recruitment exclusion distant metastasis time recruitment former radiotherapy pelvis abdomen former chemotherapy kind malign tumor ( except adequate treat skin basalioma situ cervical carcinoma ) last 5 year general contraindication know hypersensitivity Cetuximab and/or Capecitabine Non malign disease , contraindication radiotherapy chemotherapy Cetuximab Capecitabine resection rectum : highgraded cardiac insufficiency , angina pectoris , hypertension arrhythmia , hepatic disease , significant neurological psychiatric disorder florid , serious infection time recruitment legally limited contractual capability evidence neurological psychiatric disease , constrict patient compliance opinion investigator evidence lack cooperation patient pregnant breast feeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>pilot study</keyword>
	<keyword>rectal</keyword>
	<keyword>cancer</keyword>
	<keyword>phase II</keyword>
	<keyword>preoperative</keyword>
	<keyword>chemoradiation</keyword>
	<keyword>capecitabine</keyword>
	<keyword>cetuximab</keyword>
	<keyword>operable</keyword>
	<keyword>T4</keyword>
	<keyword>ABCSG</keyword>
	<keyword>TAKO</keyword>
	<keyword>R03</keyword>
	<keyword>96</keyword>
	<keyword>06</keyword>
</DOC>